FP7H2020HORIZON
St George's Hospital Medical School
- Country
- GBUnited Kingdom
- Defence projects
- 0
- Projects, all programmes
- 55
- As coordinator
- 9
- EU contribution (CORDIS)
- EUR 27,910,914
- Active
- 2008 to 2025
Projects
55 projects, newest first
| Project | Programme | Year | Role | EU contribution |
|---|---|---|---|---|
| CHAARMCombined Highly Active Anti-retroviral Microbicides | FP7 | 2010 | Participant | EUR 432,200 |
| NEOMEROEuropean multicenter network to evaluate pharmacokinetics, safety and efficacy of Meropenem in neonatal sepsis and meningitis | FP7 | 2010 | Participant | EUR 529,200 |
| SOMABIOEasy and rapid generation of light-emitting somatic-transgenic mice to monitor specific disease states and to screen effective drugs | FP7 | 2010 | Participant | EUR 153,912 |
| ARITMOArrhythmogenic potential of drugs | FP7 | 2010 | Participant | EUR 293,200 |
| BURULIVACIdentification and development of vaccine candidates for Buruli Ulcer Disease | FP7 | 2010 | Participant | EUR 131,570 |
| EUTRAFThe European Network for Translational Research in Atrial Fibrillation | FP7 | 2010 | Coordinator | EUR 762,762 |
| MALSIGSignalling in life cycle stages of malaria parasites | FP7 | 2009 | Participant | EUR 166,000 |
| COMOFARMContained Molecular Farming – Controllable Contained Systems for High Yield and Consistency | FP7 | 2009 | Participant | EUR 438,399 |
| ATPAccess to Pharmaceuticals | FP7 | 2009 | Coordinator | EUR 469,942 |
| PILGRIMPreventing community and nosocomial spread and infection with MRSA ST 398 - instruments for accelerated control and integrated risk management of antimicrobial resistance | FP7 | 2009 | Participant | EUR 451,000 |
| STOPLATENT-TBLATENT TUBERCULOSIS: New tools for the detection and clearance of dormant Mycobacterium tuberculosis | FP7 | 2008 | Participant | EUR 389,384 |
| INTERMALTRAININGIntervention strategies against malaria | FP7 | 2008 | Participant | EUR 215,844 |
| FADFighting Aneurysmal Diseases | FP7 | 2008 | Participant | EUR 582,000 |
| ATHEROREMOEuropean Collaborative Project on Inflamation and Vascular Wall Remodelling in Atherosclerosis | FP7 | 2008 | Participant | EUR 150,000 |
| EURONEUT-41EUROpean consortium on NEUTralising antibodies using gp41 | FP7 | 2008 | Participant | EUR 469,854 |
The country is the one the source records for the organisation’s registration (its PIC), and each profile says what it rests on. Where the record contradicts itself (the address in one country, the site name and the VAT number in another) we follow the two that agree: the Spanish research council CSIC is shown under Spain although its address is recorded in Italy. A body with sites in several countries is shown under the first of them in alphabetical order, and its profile lists the others. Beyond that we do not guess.
Where this comes from
- CORDIS: EU research projects (Horizon Europe, Horizon 2020, FP7)Last read on . Licence: Commission Decision 2011/833/EU (reuse of Commission documents). Source: CORDIS, European Commission.Participants and amounts as the Commission's CORDIS database states them (reuse under Commission Decision 2011/833/EU).
EU contribution is the amount CORDIS's open data pays to the participant. For a participant with linked third parties it may include their share (the CORDIS page prints the net); an amount the data does not hold is left out, not counted as zero. EDF factsheets state none per participant, so EDF projects count as projects but add nothing to the amounts.
Organisation-level facts only: a name, a country, a role, an amount, a year. A participant is recognised by its PIC where the source gives one, otherwise by name; the page says which. How the data is built.
Names are as CORDIS and the EDF project factsheets publish them. We do not list an organisation whose name looks like a natural person’s. If this entry is you, or a business named after you, and you want it removed, write to the contact in the imprint; the privacy notice (sections 7 and 9) says how a request is handled.